- Herbal medicine, a reliable support in COVID therapy
Alice Grigore et al, 2020, Journal of Immunoassay and Immunochemistry CrossRef - Proportion and mortality of Iranian diabetes mellitus, chronic kidney disease, hypertension and cardiovascular disease patients with COVID-19: a meta-analysis
Hamid Mirjalili et al, 2021, J Diabetes Metab Disord CrossRef - COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus
Hayder M. Al-kuraishy et al, 2021, Front. Cardiovasc. Med. CrossRef - Online Interactive Platform for COVID-19 Literature Visual Analytics (Preprint)
Addy Moran et al, 2021 CrossRef - Sustained Hyperglycemia and Its Relationship with the Outcome of Hospitalized Patients with Severe COVID-19: Potential Role of ACE2 Upregulation
Jose R. Vargas-Rodriguez et al, 2022, JPM CrossRef - Increased Risk of COVID-19 in Patients with Diabetes Mellitus—Current Challenges in Pathophysiology, Treatment and Prevention
Tomasz Gęca et al, 2022, IJERPH CrossRef - Prevalence and Determinants of COVID-19 Vaccination Uptake Were Different between Chinese Diabetic Inpatients with and without Chronic Complications: A Cross-Sectional Survey
Junjie Xu et al, 2022, Vaccines CrossRef - Association of COVID-19 with hepatic metabolic dysfunction
Ramesh Kumar et al, 2022, World J Virol CrossRef - Role of Glucagon-like Peptide-1 (GLP-1) Agonists in the Management of Diabetic Patients with or without COVID-19
Fatemeh Mirzaei et al, 2022, TOMCJ CrossRef - Clinical and laboratory COVID-19 features in hospitalized patients with concomitant diabetes mellitus type 2: A retrospective study
Arailym Abilbayeva et al, 2022, J CLIN MED KAZ CrossRef - Diabetes and the Skin
Justine Mestdagh et al, 2023 CrossRef - Psoriasis comorbidity management in the COVID era: a pressing challenge
Yang Song et al, 2023, Front. Microbiol. CrossRef - A predicted epithelial-to-mesenchymal transition-associated mRNA/miRNA axis contributes to the progression of diabetic liver disease
Alina-Veronica Ghionescu et al, 2024, Sci Rep CrossRef